Texas Instruments (NASDAQ:TXN) Price Target Raised to $190.00 at Barclays
Related Articles
-
Privia Health Group (NASDAQ:PRVA) Raised to “Strong-Buy” at Baird R W
Baird R W upgraded shares of Privia Health Group (NASDAQ:PRVA – Free Report) to a strong-buy rating in a report released on Thursday morning, Zacks.com reports. PRVA has been the subject of several other reports. Bank of America lowered shares of Privia Health Group from a buy rating to a neutral rating and decreased their […]
-
Privia Health Group (NASDAQ:PRVA) Price Target Lowered to $19.00 at Barclays
Privia Health Group (NASDAQ:PRVA – Free Report) had its target price lowered by Barclays from $22.00 to $19.00 in a research report sent to investors on Monday morning, Benzinga reports. Barclays currently has an equal weight rating on the stock. A number of other research analysts have also weighed in on the stock. TD Cowen […]
-
Comparing Fractyl Health (NASDAQ:GUTS) and TriSalus Life Sciences (NASDAQ:TLSI)
Fractyl Health (NASDAQ:GUTS – Get Free Report) and TriSalus Life Sciences (NASDAQ:TLSI – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, profitability, earnings and risk. Institutional and Insider Ownership 2.6% of […]